BACKGROUND: Extrapyramidal syndrome and alterations in brain magnetic resonance images are described in patients undergoing long-term home parenteral nutrition (HPN) and in cholestatic patients. These abnormalities have been correlated to basal ganglia manganese (Mn) accumulation. METHODS: A longitudinal 1-year study was conducted on 15 patients undergoing HPN (median duration, 3.8 years; range, 1.7-10; median Mn parenteral supplementation, 0.1 mg/d). Whole-blood, plasma, intra-erythrocytes, and urinary Mn concentrations were measured and brain magnetic resonance was performed at the beginning (time 0) and after 1 year of Mn intravenous supplementation withdrawal (time 1). No patients showed psychosis, extrapyramidal syndrome, or cholestasis. RESULTS: At time zero, 10 of 15 patients (67%) showed paramagnetic accumulation on cerebral magnetic resonance images; at time 1 there was a reduction of cerebral Mn accumulation. In all patients, blood-Mn levels were significantly reduced after 1 year of Mn intravenous supplementation withdrawal. CONCLUSIONS: Patients receiving long-term HPN showed an elevated incidence of alterations in brain magnetic resonance images with a median Mn intravenous supplementation of 0.1 mg/d. Mn supplementation withdrawal significantly decreased metal levels in blood and brain storage. We noticed that the intra-erythrocyte Mn level was a good index of Mn status.
BACKGROUND:Extrapyramidal syndrome and alterations in brain magnetic resonance images are described in patients undergoing long-term home parenteral nutrition (HPN) and in cholestaticpatients. These abnormalities have been correlated to basal ganglia manganese (Mn) accumulation. METHODS: A longitudinal 1-year study was conducted on 15 patients undergoing HPN (median duration, 3.8 years; range, 1.7-10; median Mn parenteral supplementation, 0.1 mg/d). Whole-blood, plasma, intra-erythrocytes, and urinary Mn concentrations were measured and brain magnetic resonance was performed at the beginning (time 0) and after 1 year of Mn intravenous supplementation withdrawal (time 1). No patients showed psychosis, extrapyramidal syndrome, or cholestasis. RESULTS: At time zero, 10 of 15 patients (67%) showed paramagnetic accumulation on cerebral magnetic resonance images; at time 1 there was a reduction of cerebral Mn accumulation. In all patients, blood-Mn levels were significantly reduced after 1 year of Mn intravenous supplementation withdrawal. CONCLUSIONS:Patients receiving long-term HPN showed an elevated incidence of alterations in brain magnetic resonance images with a median Mn intravenous supplementation of 0.1 mg/d. Mn supplementation withdrawal significantly decreased metal levels in blood and brain storage. We noticed that the intra-erythrocyte Mn level was a good index of Mn status.
Authors: Khristy J Thompson; Jennifer Hein; Andrew Baez; Jose Carlo Sosa; Marianne Wessling-Resnick Journal: Am J Physiol Gastrointest Liver Physiol Date: 2018-05-24 Impact factor: 4.052
Authors: Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens Journal: Neuromolecular Med Date: 2009 Impact factor: 3.843
Authors: Dinamene Santos; Santos Dinamene; M Camila Batoréu; Batoreu M Camila; I Tavares de Almeida; L Davis Randall; M Luísa Mateus; Mateus M Luisa; Vanda Andrade; Andrade Vanda; Ruben Ramos; Ramos Ruben; Edite Torres; Torres Edite; Michael Aschner; Aschner Michael; A P Marreilha dos Santos; A P Marreilha Dos Santos Journal: Toxicology Date: 2013-09-20 Impact factor: 4.221
Authors: Judy L Aschner; Adam Anderson; James Christopher Slaughter; Michael Aschner; Steven Steele; Amy Beller; Amanda Mouvery; Heather M Furlong; Nathalie L Maitre Journal: Am J Clin Nutr Date: 2015-11-11 Impact factor: 7.045
Authors: Airton C Martins; Silvana Ruella Oliveira; Fernando Barbosa; Alexey A Tinkov; Anatoly V Skalny; Abel Santamaría; Eunsook Lee; Aaron B Bowman; Michael Aschner Journal: Expert Opin Drug Metab Toxicol Date: 2021-03-04 Impact factor: 4.481